在一般性焦虑症中睡眠障碍:失眠的核心作用
Yan Xue1, Wei-Dong Wang1, Yan-Jiao Liu1
1Psychological and Sleep Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 100053, Beijing, PR China.
Sleep medicine
|May 3, 2025
概括
通用焦虑症 (GAD) 和失眠有着双向的联系和重叠的神经生物学机制. 用对失眠的认知行为疗法 (CBT-I) 治疗失眠可以改善GAD症状.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
背景情况:
- 泛性焦虑障碍 (GAD) 是一种慢性疾病,在全球范围内影响3-6%,以过度担忧和紧张为特征.
- 睡眠障碍,特别是失眠,是GAD的常见和使人虚弱的症状.
- 失眠会使焦虑症状恶化,甚至可能在GAD发展之前出现.
研究的目的:
- 审查临床和神经生物学的证据,关于GAD和失眠之间的双向关系.
- 要突出共同的病理生理机制,这两个条件的基础.
- 讨论治疗的影响,特别是以睡眠为中心的干预措施的作用.
主要方法:
- 审查关于GAD和失眠的新兴研究.
- 神经生物学和神经成像研究的分析.
- 对治疗结果的临床证据的审查.
主要成果:
- GAD和失眠表现出一种相互关系,影响对方的严重程度.
- 共同的神经生物学机制包括HPA轴过度活跃,杏仁体反应性和GABAergic缺陷.
- 失眠的认知行为疗法 (CBT-I) 在改善睡眠和减少GAD症状方面表现出有效性.
结论:
- GAD和失眠之间的相互作用是关键的,并通过共享的神经生物学途径得到加强.
- 解决失眠问题对于有效管理GAD至关重要.
- 将CBT-I等以睡眠为重点的干预措施整合到GAD治疗中是一个有希望的方法.
相关概念视频
Generalized Anxiety Disorder
29
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
29
Insomnia
75
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
75
Management of Insomnia
185
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
185
Anxiety: Overview
204
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
204
CNS Depressants: Barbiturates and Benzodiazepines
165
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
165
Sedatives and Hypnotics Drugs: Miscellaneous Agents
97
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
97


